Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
Inhibrx, Inc. posts annual revenue of $2.19 million in 2022
By USInMinutes - Apr 10, 2023, 09:08 PM ET
Last Updated - Jul 18, 2023, 03:59 PM EDT
Key fundamental financials- profit of $145.23 million
- Revenue of $2.19 million
Inhibrx, Inc. [INBX] has reported $145.23 million profit for the fiscal year ending Dec 31, 2022.
Revenue for the year was $2.19 million with operating income of $129.12 million.
The Lajolla, California (CA)-based company operating in the biological products, except diagnostic substances sector with 141 employees has total shareholders equity of $58.06 million.
Also read:
This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.
Sponsored
Read More from Annual Reports
Read More from USinMinutes
Popular News
Latest News